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Background: Although both the mother’s and father’s alleles are present in the offspring,
they may not operate at the same level. These parent-of-origin (PoO) effects have not
yet been explored on the X chromosome, which motivated us to develop new methods
for detecting such effects. Orofacial clefts (OFCs) exhibit sex-specific differences in
prevalence and are examples of traits where a search for various types of effects on
the X chromosome might be relevant.
Materials and Methods: We upgraded our R-package Haplin to enable genome-wide
analyses of PoO effects, as well as power simulations for different statistical models.
14,486 X-chromosome SNPs in 1,291 Asian and 1,118 European case-parent triads of
isolated OFCs were available from a previous GWAS. For each ethnicity, cleft lip with or
without cleft palate (CL/P) and cleft palate only (CPO) were analyzed separately using two
X-inactivation models and a sliding-window approach to haplotype analysis. In addition,
we performed analyses restricted to female offspring.
Results: Associations were identified in “Dystrophin” (DMD, Xp21.2-p21.1), “Fibroblast
growth factor 13” (FGF13, Xq26.3-q27.1) and “EGF-like domain multiple 6” (EGFL6,
Xp22.2), with biologically plausible links to OFCs. Unlike EGFL6, the other associations
on chromosomal region Xp22.2 had no apparent connections to OFCs. However,
the Xp22.2 region itself is of potential interest because it contains genes for clefting
syndromes [for example, “Oral-facial-digital syndrome 1” (OFD1) and “Midline 1” (MID1)].
Overall, the identified associations were highly specific for ethnicity, cleft subtype and
X-inactivation model, except for DMD in which associations were identified in both CPO
and CL/P, in the model with X-inactivation and in Europeans only.
Discussion/Conclusion: The specificity of the associations for ethnicity, cleft subtype
and X-inactivation model underscores the utility of conducting subanalyses, despite the
Skare et al. X-Linked Parent-of-Origin (PoO) Effects in Orofacial Clefts
ensuing need to adjust for additional multiple testing. Further investigations are needed
to confirm the associations with DMD, EGF16, and FGF13. Furthermore, chromosomal
region Xp22.2 appears to be a hotspot for genes implicated in clefting syndromes and
thus constitutes an exciting direction to pursue in future OFCs research. More generally,
the new methods presented here are readily adaptable to the study of X-linked PoO
effects in other outcomes that use a family-based design.
Keywords: parent-of-origin, X chromosome, GWAS, case-parent triads, orofacial clefts, birth defects, genetic
epidemiology, Haplin
INTRODUCTION
Orofacial clefts (OFCs) are the most common craniofacial birth
defects in humans, affecting approximately 1–2/1000 live births
worldwide (Mossey et al., 2009). They are broadly categorized
according to whether the affected region includes the primary
palate, the secondary palate, or both, and whether they occur
with or without additional congenital anomalies (Dixon et al.,
2011; Marazita, 2012; Beaty et al., 2016). OFCs pose a substantial
public health burden in terms of the medical costs and sequelae
associated with their treatment, which may persist from infancy
to childhood and throughout life (Wehby and Cassell, 2010;
Berg et al., 2016a,b). OFCs have also been linked to higher risk
of specific types of cancer in later life (Zhu et al., 2002; Bille
et al., 2005), increased overall mortality well into adulthood
(Christensen et al., 2004), and lower academic achievement
(Wehby et al., 2014). Despite major progress in surgery and other
medical interventions aimed at repairing and managing the cleft
itself, current understanding of the biological underpinnings of
these relatively common birth defects is still incomplete.
Both genetic and environmental factors have been reported to
influence the risk of OFCs, either individually or through their
complex interactions in relevant biological pathways (Jugessur
et al., 2009a; Dixon et al., 2011; Marazita, 2012; Rahimov
et al., 2012; Beaty et al., 2016; Kousa and Schutte, 2016).
Genome-wide association studies (GWAS) have successfully
identified several genes and loci for OFCs, contributing to an
improved understanding of the biological processes underlying
these relatively common birth defects (Birnbaum et al., 2009;
Grant et al., 2009; Beaty et al., 2010; Mangold et al., 2010;
Camargo et al., 2012; Ludwig et al., 2012; Wolf et al., 2015; Leslie
et al., 2016a,c). However, most of the genetic variation in OFCs
remains unexplained. Given the more than 30-fold increased
risk of recurrence in first-degree relatives of patients with OFCs
(Sivertsen et al., 2008; Grosen et al., 2010), exploring alternative
genetic mechanisms beyond simple fetal or maternal gene-effects
alone may be important. This entails investigating higher-order
interactions, such as epistasis (Cordell, 2009; Wei et al., 2014)
and gene-environment interaction (Thomas, 2010), and studying
parent-of-origin (PoO) effects (Ferguson-Smith, 2011; Guilmatre
and Sharp, 2012; Lawson et al., 2013; Peters, 2014; Connolly and
Heron, 2015; Gjerdevik et al., 2017; Haaland et al., 2017).
A PoO effect describes the situation where the effect of an
allele in the offspring differs according to the parental origin of
the allele (Guilmatre and Sharp, 2012; Gjerdevik et al., 2017).
PoO effects are particularly relevant for birth defects because
the mother influences the development of the fetus through the
action of her own genes and through providing the prenatal
environment for the fetus. To estimate PoO effects, one contrasts
the frequency of alleles transmitted to an affected offspring from
the mother versus the father, and if transmission distortion to
the affected offspring is stronger for mothers than fathers (or vice
versa), there is evidence of a PoO effect (Weinberg, 1999; Jugessur
et al., 2012b; Connolly and Heron, 2015). PoO effects might also
occur on the X chromosome. Given the consistently observed
excess of females with cleft palate only (CPO) and excess of males
with cleft lip with or without cleft palate (CL/P), OFCs are good
examples of traits that might be caused by various types of effects
on the X chromosome (including PoO effects). Moreover, several
genes on the X chromosome are known to cause syndromic forms
of clefts, and there is growing evidence that X-linked genes might
also contribute to isolated clefts (Jugessur et al., 2012a; Patel et al.,
2013; Fonseca et al., 2015; Wise et al., 2016; Skare et al., 2017).
A major shortcoming of most previous GWAS has been the
systematic exclusion of SNPs on the X chromosome prior to
analysis, even though this chromosome comprises approximately
5% of the human genome and many genotyping platforms do
include X-linked SNPs. This has led to only a few analyses of X-
linked markers for complex traits in general (Wise et al., 2013),
and for OFCs in particular, only two studies have explored PoO
effects at the genome-wide level (Shi et al., 2012; Garg et al., 2014),
and neither investigated PoO effects on the X chromosome.
With these gaps in mind, we upgraded our R-package Haplin
(Gjessing and Lie, 2006) with new functionalities to enable PoO
analyses at the genome-wide level, as well as an assessment
of statistical power for different statistical models. The current
analyses are based on the largest collection of case-parent
triads of OFCs to date (Beaty et al., 2010). We implemented a
sliding-window approach to haplotype analysis and used two X-
inactivation models, one with and one without the assumption
of X-inactivation in females (Yang et al., 2011), to explore PoO
effects on the X chromosome. In addition, we performed separate




Characteristics of the study populations, the genotyping
platform, and the quality control criteria used for data cleaning
have been detailed elsewhere (Beaty et al., 2010; Shi et al., 2012;
Patel et al., 2013; Skare et al., 2017). Briefly, genotyping was
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performed on an Illumina Human610-Quad R© platform and
genotypes for 589,945 SNPs (99.56% of the attempted SNPs) were
released and later deposited in the Database of Genotypes and
Phenotypes (dbGaP; http://www.ncbi.nlm.nih.gov/gap) under
study accession ID phs000094.v1.p1. Genotypes for 14,486 X-
chromosome SNPs in 1,291 Asian and 1,118 European case-
parent triads of isolated clefts were available for the current
analyses. For additional data cleaning, we used PLINK (Purcell
et al., 2007) to exclude individuals with more than 10% missing
genotypes, SNPs withmore than 1%missing genotypes, and SNPs
with a minor allele frequency (MAF) less than 0.01. Mendelian
errors were not assessed during data cleaning; however, SNPs
withmore than 30Mendelian errors were excluded at the analysis
stage. After data cleaning, 13,180 X-chromosome SNPs were
available for the current PoO analyses. Table 1 shows the number
of triads according to ethnicity, cleft subtype and child’s sex.
For each ethnicity, isolated CL/P and isolated CPO triads were
analyzed separately.
Statistical Methods
We recently published a new approach to chromosome-wide
analysis of X-linked SNPs using the same dataset as here (Skare
et al., 2017). In the current paper, we extend the approach to also
cover PoO effects on the X chromosome, as implemented in our
statistical software Haplin (Gjessing and Lie, 2006). Two types of
analyses were performed on the Asian and European samples: (i)
Single-marker analyses, where SNPs were analyzed individually,
and (ii) haplotype analyses, where up to four SNPs per sliding
window were analyzed together. Haplin fits a log-linear model to
genotype data from case-parent triads. It reconstructs haplotypes
from multiple-SNP data and estimates the relative risk and
confidence interval for one or two copies of a target allele
or haplotype. Since the expectation-maximization algorithm is
implemented in Haplin, incomplete triads can also be used in the
analyses after accounting for missing parental genotypes in the
maximum likelihood estimation.
For haplotype analysis, we used the HaplinSlide function
in Haplin. For additional information on data formats and
the HaplinSlide function, see our recent chromosome-wide
analysis of X-linked SNPs (Skare et al., 2017), our website at
https://people.uib.no/gjessing/genetics/software/haplin/, or the
R help pages for Haplin at https://CRAN.R-project.org/package=
Haplin.
TABLE 1 | Number of case-parent triads according to ethnicity, cleft subtype, and
child’s sex.
Ethnicity Cleft category No. of case-parent triads
Males Females Total
Asian CL/P 681 357 1,038
Asian CPO 100 153 253
Total CL/P + CPO 781 510 1,291
European CL/P 536 304 840
European CPO 131 147 278
Total CL/P + CPO 667 451 1,118
Estimating PoO Effects on the X
Chromosome Using Haplin
Within the maximum-likelihood framework of Haplin,
autosomal PoO effects are derived essentially by contrasting the
relative frequency of the variant allele when transmitted from
the mother to the affected child versus the relative frequency
of the variant allele when transmitted from the father; there is
evidence of a PoO effect if the frequencies differ (Weinberg, 1999;
Gjerdevik et al., 2017). Haplin provides estimates of RRm and
RRf, which are the relative risk increase (or decrease) associated
with inheriting the variant allele from the mother and from
the father, respectively. The measure of PoO effect is then the
ratio of relative risks, RRR = RRm/RRf, i.e., the PoO effect is
a comparison of the relative risks derived from the maternally
and paternally inherited alleles. A value of RRR = 1 would be
obtained from an allele with no PoO effect, i.e., RRm = RRf.
Note that even when RRR = 1, RRm and RRf could themselves
still be different from 1, meaning that there could be an effect of
the allele carried by the fetus even in the absence of a PoO effect.
Under a multiplicative model, the risk is assumed to be RRm∗RRf
when the allele is inherited both from the mother and the father
(i.e., a double dose of the variant allele).
Similarly, on the X chromosome, the estimates of RRm and
RRf can be obtained by restricting the analyses to girls only.
However, since the X chromosome in boys is maternally derived,
Haplin allows an increase in power by combining the relative risk
estimate RRB from boys with the estimates from girls. The two
options for doing so assume either X-inactivation among girls,
where RRm∗RRf = RRB, or no X-inactivation, where RRm =
RRB. Note that in the model assuming X-inactivation, equating
the estimate RRB from the boys with the product of RRm and
RRf may influence the RRm and RRf estimates themselves, but
has relatively little influence on the ratio RRR. When studying
the significance of PoO specifically, the hits obtained from
investigating girls only will thus be similar to those obtained
from the model assuming X-inactivation. The combined model
assuming no X-inactivation, however, may well produce other
hits. Both combined models allow different baselines risks for
boys and girls to be fitted.
Figure 1 provides a detailed explanation of the Haplin model
for PoO effects on the X chromosome.
Post-processing of Results
For each cleft subtype, –log10(p) were plotted against
chromosomal position in a Manhattan plot, before all the
Manhattan plots were collated and displayed in a single figure.
To control for the proportion of falsely rejected hypotheses, we
applied a false discovery rate (FDR) method where the original
p-values were replaced by “q-values” (Storey and Tibshirani,
2003). For example, among SNPs with a q-value≤ 0.2, one would
expect an FDR of less than 20%.
Electronic Database Information
Haplin version 6.2.1 is implemented as a package in the R
statistical software (R Development Core Team, 2014) and can be
installed from the CRAN library. More information can be found
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FIGURE 1 | An illustration of the Haplin model for parent-of-origin (PoO)
effects on the X chromosome. The red arrows show the relative risks
associated with girls inheriting the risk allele “a” from the mother (RRm) or from
the father (RRf ). Under the multiplicative risk model illustrated here, the relative
risk increase for “aa” girls, i.e., girls inheriting allele “a” from both the mother
and the father, is RRaa = RRm*RRf. The ratio RRm/RRf = 1.4 is a measure of
the PoO effect (blue arrow). The risk increase for boys when inheriting the “a”
allele is RRB = 2.0. Under the assumption of X-inactivation (A), the risk
increase for girls inheriting “aa” is the same as that for a single “a” in boys, i.e.,
RRaa = RRB. Under the assumption of no X-inactivation (B), the risk increase
for girls inheriting “a” from the mother is the same as that for boys, i.e., RRm =
RRB. In the model without X-inactivation, when a girl inherits “a” from the
father as well, this may lead to a higher total risk increase for girls than for boys
inheriting the one “a” from the mother. In this illustration, RRaa = RRm*RRf =
2.86 > RRB. The model allows different baseline risks for girls and for boys,
here 0.4 and 0.5%, respectively.
at our web site (https://people.uib.no/gjessing/genetics/software/
haplin/).
Ethics Approval
Ethics approvals for the International Cleft Consortium were
obtained from the respective institutional review boards of the
participating sites. The consortium was formed in 2007 and
each participating institution approved research protocols for
the recruitment of case-parent triads from 13 individual sites.
All participants have granted their written informed consents.
The participating sites included institutions in the US (Johns
Hopkins University; University of Iowa; Utah State University;
National Institute of Environmental Health Sciences (NIEHS);
University of Pittsburgh), Denmark (University of Southern
Denmark), Norway (University of Bergen), China (Peking
University Health Science Center; Wuhan University; Peking
Union Medical College; West China School of Stomatology,
Sichuan University; School of Stomatology, Beijing University),
Korea (Yonsei University), Taiwan (Chang Gung Memorial
Hospital), and Singapore (KK Women’s & Children’s Hospital;
National University of Singapore). For more details on the
recruitment sites, the research approvals and protocols, see the
online “Supplementary Note” of the original publication (Beaty
et al., 2010), as well as the study outline at dbGAP (https://
www.ncbi.nlm.nih.gov/gap), under study accession number
phs000094.v1.p1.
RESULTS
The results are organized in two main parts: (Part A) presents the
results of the analyses of the boys and girls together (Figure 2),
and (Part B) presents the results of the analyses of the girls only
(Figure 3). For each of the X-inactivation models depicted in
Figure 2, the results of the single-marker analyses are presented
first, followed by the results of the haplotype analyses. Table 2
provides additional information on the SNPs and haplotypes,
along with their relative risks (RRs) and 95% confidence intervals
(CIs). Note that the Manhattan plots for the single-marker and
haplotype analyses (Figures 2, 3) only show the lead SNPs and
haplotypes. A more complete list of SNPs and haplotypes lying
above the p-value cutoff of 10−4 in Figures 2, 3 is provided in
Table 2.
Figure 4 shows the results of power simulations for different
statistical models (girls only, without X-inactivation, with X-
inactivation), based on sample sizes reflecting those available
in the current GWAS dataset. Table 3 provides a synopsis
of all the genes in which associations were identified in
the current analyses. To determine whether a given SNP or
haplotype was located in or near a gene within 20 kb, we
used the 1,000 Genomes browser (https://www.ncbi.nlm.nih.gov/
variation/tools/1000genomes).
(A) Single-Marker and Haplotype Analyses
Combining Estimates from Boys and Girls
Figure 2 displays the results of the single-marker and haplotype
analyses in the Asian and European samples for each X-
inactivation model.
(i) Asian Sample
There were no associations in the single-marker analyses of
isolated CPO or isolated CL/P in the model without X-
inactivation. By contrast, three SNPs stood out in the model
with X-inactivation: rs5935623 in CPO; and both rs12690207 and
rs2405829 in CL/P. rs5935623 is located in the gene for “EGF-
like domainmultiple 6” (EGFL6 at Xp22.2), rs12690207 is located
in “Fibroblast growth factor 13” (FGF13 at Xq26.3-q27.1), and
rs2405829 is located in “Dystrophin” (DMD at Xp21.2-p21.1).
In haplotype analyses, haplotype rs6527993-rs4969754-
rs5990881-rs4969757 was associated with CL/P in the
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FIGURE 2 | Single-marker and haplotype analyses in the Asian and European samples without stratification by child’s sex. The Manhattan plots show the
single-marker and haplotype analyses based on the model without and with X-inactivation in females, respectively. For convenience, we have added a vertical line
corresponding to a Bonferroni-corrected p-value cutoff of 10−4.
model without X-inactivation. Although the q-value for
this haplotype was 0.008 (Table 2), none of the SNPs
is located in or near a gene within 20 kb. In the model
with X-inactivation, we found associations with two
haplotypes: (i) rs4366220-rs5928243-rs988530-rs5928245
in CPO and (ii) rs5979748-rs2162-rs5935409-rs5935412
in CL/P. The first SNP in haplotype (i) lies ∼9.7 kb from
DMD, and the first SNP in haplotype (ii) lies ∼5.3 kb from
“Phosphoribosyl pyrophosphate synthetase 2” (PRPS2 at
Xp22.2).
(ii) European Sample
In the model without X-inactivation, we found associations with
rs4559361, rs5933262, and rs4128285 in CPO (all three SNPs
had the same q-value of 0.155; Figure 2, Table 2). rs4559361
lies ∼4.4 kb from the gene for “SPANX family, member N4”
(SPANXN4 at Xq27.3), rs5933262 is located in “Ubiquitin specific
peptidase 26” (USP26 at Xq26.2), and rs4128285 is not located
near any gene within 20 kb. In the model with X-inactivation,
rs6529005 was associated with CPO. This SNP is not located near
any gene within 20 kb.
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FIGURE 3 | Single-marker and haplotype analyses in the Asian and European girls only. The Manhattan plots show the single-marker and haplotype analyses of the
girls only. For convenience, we have added a vertical line corresponding to a Bonferroni-corrected p-value cutoff of 10−4.
In haplotype analyses, rs2024759-rs6609469-rs743046-
rs2498183 was associated with CPO in the model without
X-inactivation. The last SNP in this haplotype is located
∼24.2 kb from “Zinc finger protein 157” (ZNF157 at Xp11.3). In
the model with X-inactivation, four haplotypes were associated
with CPO, but only rs1139916-rs2266856-rs5925077-rs5925079
(q = 0.169) has SNPs located in a specific gene—in “Gamma-
aminobutyric acid type A receptor epsilon subunit” (GABRE at
Xq28).
(B) Single-Marker and Haplotype Analyses
Restricted to Girls Only
Figure 3 displays the results of the single-marker and haplotype
analyses restricted to the Asian and European girls only.
(i) Asian Sample
In single-marker analyses, we identified associations with the
same three SNPs (rs5935623 in CPO, and both rs12690207
and rs2405829 in CL/P) as in the single-marker analyses based
on the model with X-inactivation (Figure 2). In the haplotype
analyses, two of the haplotypes that were associated in the
analyses based on the model with X-inactivation (Figure 2)
were also identified here and in the same cleft categories;
notably, rs4366220-rs5928243-rs988530-rs5928245 in CPO and
rs5979748-rs2162-rs5935409-rs5935412 in CL/P. There were
two additional haplotypes associated with CPO: (i) rs982598-
rs12843271-rs4826609-rs5961136 and (ii) rs6639176-rs5978529-
rs1874039-rs5978530. The last SNP in haplotype (i) is located
in “Inter-alpha-trypsin inhibitor heavy chain family member 6”
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FIGURE 4 | Statistical power for a single SNP. (A) Shows the simulated power for the model restricted to girls only, (B) shows the simulated power for the model
without X-inactivation, and (C) shows the simulated power for the model with X-inactivation. The figures on the left depict the power with increasing relative risk ratios
(RRRs) (increasing values of RRm; RRf = 1) and differing sample sizes of case-parent triads, using a fixed minor allele frequency (MAF) of 0.2. The figures on the
right-hand side show the power with varying RRRs and MAFs, assuming a total of 300 case-parent triads for the girls-only analyses in (A) and 600 case-parent triads
in (B,C) (assuming an equal distribution of boys and girls). We used a nominal significance level of 0.05 throughout.
(ITIH6 at Xp11.22), while the SNPs in haplotype (ii) are
located in “FERM and PDZ domain containing 4” (FRMPD4 at
Xp22.2).
(ii) European Sample
In single-marker analyses, rs6529005 (q = 0.161) was associated
with CPO, which was also identified in the single-marker
analyses in the same cleft category based on the model with X-
inactivation (Figure 2). There were no associations with CL/P.
In the haplotype analyses, the same SNP identified in the
single-marker analysis above, rs6529005, appeared to be driving
the association here between rs2869525-rs6529005-rs2180212-
rs5954651 and CPO. One more haplotype was associated with
CPO: rs10521639-rs12115935-rs16979405-rs12009996. Both of
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EGFL6 (Xp22.2) EGF like domain
multiple 6
EGFL6 is an EGF-repeat containing gene belonging to
the EGF-repeat superfamily. Members of this gene family
are involved in cell cycle regulation and proliferation. The
mouse homolog, Egf16, is strongly expressed in the
mesenchymal components of both the hard and soft
palate from embryonic stage E12.5.
Buchner et al., 2000a,b
FGF13 (Xq26.3-q27.1) Fibroblast growth
factor 13
FGF13 belongs to the FGF family of signaling
molecules—one of the largest growth factor families.
FGF signaling is essential to the development of
craniofacial structures. Several FGF ligands and
receptors are expressed in the developing facial
primordia, and mutations in FGF receptors are known to
cause different clefting syndromes (e.g. Kallmann and
Apert).
Nie et al., 2006; Rahimov
et al., 2012; Du et al., 2016
DMD (Xp21.2-p21.1) Dystrophin Dystrophin is a component of the
dystrophin-glycoprotein complex whose function is to
provide stability to muscle membranes by bridging the
cytoskeleton of the muscle to the extracellular matrix.
Mutations in DMD cause Duchenne (DMD) and Becker
(BMD) Muscular Dystrophies. Associations between
variants in DMD and OFCs have been reported in four
chromosome-wide analyses of X-linked SNPs.
Michele and Campbell, 2003;
Patel et al., 2013; Fonseca
et al., 2015; Wise et al., 2016;
Skare et al., 2017
Asian; No
X-inactivation




This gene encodes a phosphoribosyl pyrophosphate
synthetase that plays a central role in protein and
nucleotide biosynthesis.





SPANXN4 (Xq27.3) SPANX family
member N4
SPANXN4 belongs to the SPANX multigene family of
cancer/testis-specific antigens that play important roles
in spermiogenesis.
Kouprina et al., 2004
USP26 (Xq26.2) Ubiquitin specific
peptidase 26
USP26 belongs to a large family of deubiquitinating
enzymes and this gene is specifically expressed in testis
tissue. Variants in USP26 have been linked to male
infertility in some but not all studies.
Stouffs et al., 2005; Wosnitzer




Haplotype ZNF157 (Xp11.3) Zinc finger protein
157
ZNF157 belongs to the zinc-finger family of transcription
factors. ZNF157 is part of a gene cluster of ZNF genes
on chromosome Xp11.23.





GABRE encodes the “Gamma-aminobutyric acid type A
receptor epsilon subunit.” This gene maps to a cluster
on chromosome Xq28 that houses other subunits of the
same receptor. Fatemi et al. (2013) reported increased
expression of GABRE in the lateral cerebella of subjects
with schizophrenia, bipolar disorder and major
depressive disorder.
Fatemi et al., 2013
Asian; Girls only Single-
marker
EGFL6 (Xp22.2) EGF like domain
multiple 6
As above. As above.
FGF13 (Xq26.3-q27.1) Fibroblast growth
factor 13
As above. As above.
DMD (Xp21.2-p21.1) Dystrophin As above. As above.




ITIH6 encodes a protein belonging to the inter-alpha
trypsin inhibitor heavy chain (ITIH) family. Al-Mubarak
et al. (2017) performed whole-exome sequencing of
autism spectrum disorders (ASD) triads and uncovered
rare variants in several X-linked genes, including ITIH6.
Al-Mubarak et al., 2017
(Continued)
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Gene ID (location)a Gene full name Gene description and additional commentsb Key references
FRMPD4 (Xp22.2) FERM and PDZ
domain containing
4
FRMPD4 encodes a multi-domain (PDZ and FERM)
containing protein. It modulates the activity of key
postsynaptic scaffold proteins that are involved in
cognitive processes. Variants in FRMPD4 have been
associated with X-linked intellectual disability and
schizophrenia.
Hu et al., 2016; Matosin et al.,




As above. As above.
aGenes located within the same chromosomal band Xp22.2 are emboldened.
b Information on these genes was collated from the NCBI Entrez gene database (https://www.ncbi.nlm.nih.gov/gene) and the references shown.
these haplotypes were already identified in the haplotype analyses
based on the model with X-inactivation (Figure 2), but none of
the SNPs in these haplotypes is located near any known gene
within 20 kb.
Power Simulations
Haplin includes a complete framework for power simulations
(Gjerdevik et al., 2017). Figure 4 displays the a priori power
calculations for a single SNP to detect PoO effects on the X
chromosome. All calculations were based on 1,000 simulated
datasets with a 0.05 nominal significance level (note that a
baseline risk of one was used throughout). The power of a single
SNP to detect PoO effects on the X chromosome depends on
several factors, including theminor allele frequency (MAF), effect
size, sample size and family design. The power of the model
focusing on girls only is similar to that of the model with X-
inactivation in females (Figures 4A,C), which is consistent with
the fact that those models provide similar estimates of RRR (as
also mentioned in the Materials and Methods section). Overall,
the power is sufficient for RRRs > 2, with the range of MAFs
and sample sizes presented in our analyses (RRRs ≥ 2.5 for the
smallest sample sizes).
DISCUSSION
Our analyses detected possible PoO effects with several SNPs and
haplotypes on the X chromosome, some of which were located
in or close to genes (summarized in Table 3). Perhaps the most
prominent gene on the list is “Dystrophin” (DMD), the second
largest gene in humans according to the size of the transcript and
protein product (Richards and Hawley, 2011). Dystrophin forms
part of the dystrophin-glycoprotein complex whose function is to
provide mechanical stability to the plasma membrane of striated
muscle cells (Michele and Campbell, 2003; Gao and McNally,
2015). Several lines of evidence point to a link between muscular
dystrophy and OFCs. For example, both congenital muscular
dystrophy and CL/P have been observed in the rare autosomal-
recessiveWalker-Warburg syndrome (Moore et al., 1988; Dobyns
et al., 1989; Pratap et al., 2007; Vajsar et al., 2008). More recently,
we and others have reported associations between OFCs and
variants in DMD in several chromosome-wide studies of X-
linked SNPs (Patel et al., 2013; Fonseca et al., 2015; Wise et al.,
2016; Skare et al., 2017). Even though only the Fonseca et al.
(2015) study was based on a different GWAS dataset and study
population compared to the other three studies, the repeated
identification of DMD nevertheless constitutes an exciting new
direction to pursue in future OFCs research.
Besides DMD, we identified PoO effects with several other
genes, two of which—EGFL6 and FGF13—offer biologically
plausible links to OFCs. EGFL6 belongs to the EGF-repeat
containing superfamily of genes known to be involved in
cell cycle regulation and proliferation (Buchner et al., 2000a).
Expression analyses of murine Egf16 show strong expression in
the mesenchymal components of both the hard and soft palate
from embryonic stage E12.5 (Buchner et al., 2000b). This spatio-
temporal pattern of gene expression supports a role for EGFL6 in
the development of the orofacial complex, but as with DMD, the
associations with EGFL6 will need to be validated in other OFCs
samples.
FGF13 belongs to the FGF family of signaling molecules
known to play key roles in embryonic development (Nie et al.,
2006; Rahimov et al., 2012; Du et al., 2016). Several FGF ligands
and receptors are expressed in the developing facial primordia,
and mutations in specific FGF receptors have been reported to
cause clefting syndromes (Rahimov et al., 2012). For example,
Kallmann syndrome is caused by mutations in FGFR1 (Dodé
et al., 2003) whereas Apert syndrome is caused by mutations in
FGFR2 (Wilkie et al., 1995). FGF13 is thus a promising gene to
pursue in other independent cleft samples.
As opposed to the above genes, there are no obvious
connections between OFCs and the remaining genes in Table 3.
It is nonetheless noteworthy that both PRPS2 and FRMPD4 are
located in chromosomal region Xp22.2, which is also the location
of EGFL6 whose link to OFCs was discussed above. Figure 5 is
a collage of screenshots showing all the genes in chromosomal
region Xp22.2 as they appear in the genome browser of The
Ensembl Project (Kersey et al., 2016; Yates et al., 2016). This
chromosomal region contains two genes that have been linked to
clefting syndromes. The first is “Oral-facial-digital syndrome 1”
(OFD1), a gene in which we had previously identified associations
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FIGURE 5 | Genes located in chromosomal region Xp22.2. This collage of screenshots of chromosomal region Xp22.2 was generated using the Ensembl genome
browser (http://www.ensembl.org/) (Kersey et al., 2016; Yates et al., 2016). The three genes identified in this study are shown in boxes, in addition to the
“Oral-facial-digital syndrome 1” (OFD1) gene, in which we had identified associations in our previous study on candidate genes on the X chromosome (Jugessur et al.,
2012a), and the “Midline 1” (MID1) gene.
with OFCs in a candidate-gene analysis of X-linked markers
(Jugessur et al., 2012a). Mutations in OFD1 underlie the X-
linked dominant oral-facial digital syndrome type 1, which is
characterized by malformations of the face, oral cavity and digits,
and lethality in most affected males (Ferrante et al., 2001). The
orofacial abnormalities in Oral-facial-digital syndrome 1 include
median cleft lip, clefts of the alveolar ridge, and cleft palate. The
second gene in chromosomal region Xp22.2 region is “Midline
1” (MID1). Mutations in this gene cause the X-linked Opitz
GBBB syndrome, a congenital midline malformation syndrome
featuring clefting of the lip and palate as part of the overall
clinical picture (Quaderi et al., 1997). Furthermore, associations
between isolated CL/P and specific haplotypes inMID1 have been
reported in an Italian population (Scapoli et al., 2008).
As seen in Figure 5, MID1, FRMPD4, PRPS2, EGFL6, and
OFD1 all lie relatively close to one another on chromosome
Xp22.2. Specifically, MID1 is ∼1.3Mb from FRMPD4, FRMPD4
is ∼66.8 kb from PRPS2, PRPS2 is ∼745.3 kb from EGFL6,
and EGFL6 is ∼81.8 kb from OFD1. Aside from the potential
contributions of the genes themselves, their shared location on
Xp22.2 suggests that there might be a specific locus (or loci)
in that region driving the associations detected by our PoO
analyses—a hypothesis worth pursuing in other OFCs samples.
In addition, the apparent excess of genes on the X chromosome
that are associated with sexually dimorphic traits (Saifi and
Chandra, 1999; Vawter et al., 2004; Berletch et al., 2011) makes
genes that escape X-inactivation (Yang et al., 2011; Deng et al.,
2014; Balaton and Brown, 2016) particularly attractive candidates
in explaining some of the observed male-female differences
in development and physiology (Ober et al., 2008; Berletch
et al., 2011). Such a scenario would be captured by our model
assuming no X-inactivation (Figure 1B). Since both CL/P and
CPO consistently exhibit a skewed sex ratio in prevalence, it may
be worth exploring this hypothesis in future studies of PoO effects
in OFCs. In addition, scenarios involving variable escape from X-
chromosome inactivation (Peeters et al., 2014) are also amenable
to testing using the X-inactivation models in Haplin.
Identifying associations between isolated OFCs and genes
for clefting syndromes is not surprising, as it has long been
recognized that Mendelian forms of clefting that phenocopy
isolated clefts may provide important clues in identifying genes
involved in isolated forms of clefts (Jugessur and Murray,
2005). One of the best examples to date is Van der Woude
syndrome (VWS), in which hypodontia and lip pits are the only
additional features distinguishing patients with VWS from those
with isolated clefts. Mutations in interferon regulatory factor 6
(IRF6) were reported to cause VWS (Kondo et al., 2002), and,
subsequently, we and others reported associations between IRF6
variants and isolated clefts (Zucchero et al., 2004; Jugessur et al.,
2008, 2009b; Beaty et al., 2013; Leslie et al., 2016b; Moreno
Uribe et al., 2017). Our current identification of several genes
associated with clefting syndromes, while studying isolated OFCs
per se, supports the notion that there may be a wider spectrum
of subclinical features beside the overt cleft itself, blurring the
distinction between isolated and non-isolated clefts.
Indeed, a handful of subclinical features have been
characterized in patients who were initially classified as
“isolated” cleft cases, as well as in their immediate family
members (Weinberg et al., 2006; Jugessur et al., 2009a; Marazita,
2012). The inclusion of one such subclinical feature—breaks
in the orbicularis oris muscle in the mouth—revealed a pattern
of familial segregation more akin to that of a Mendelian
trait (Marazita, 2007; Neiswanger et al., 2007). This further
supports the existence of a wider array of subphenotypes that
are associated with the overt cleft, and the identification of
genes underlying syndromic clefts while analyzing isolated OFCs
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samples, like we do in this paper, is consistent with previous
descriptions of an “extended cleft phenotype” (Weinberg et al.,
2006; Marazita, 2007, 2012; Jugessur et al., 2009a; Rahimov et al.,
2012).
Another important factor to consider in genetic association
analyses is whether associations identified in one ethnicity are
generalizable to other ethnicities. DMD was the only gene in
which associations were identified in both CPO and CL/P,
in the model with X-inactivation, in both single-marker and
haplotype analyses, and in Europeans only. The remaining
associations were highly specific for ethnicity, cleft subtype and
X-inactivation model, with none of the associations in the Asian
sample overlapping with those in the European sample. For
example, the associations with EGFL6, FGF13, DMD, and PRPS2
were only detected in the Asian sample and in the model
with X-inactivation, whereas the associations with SPANXN4,
ZNF157, and GABRE were only observed in the European
sample. Furthermore, associations with SPANXN4 and ZNF157
were only detected in the model assuming no X-inactivation,
whereas associations with GABRE were only detected in the
model with X-inactivation. These findings challenge the common
assumption that the remarkable phenotypic consistency of OFCs
across different ethnicities is because at least a subset of
the causal variants is shared across different ethnicities. The
apparent lack of overlap between Asians and Europeans was
also observed in our recent chromosome-wide analysis of X-
linked variants in the same GWAS dataset as here (Skare et al.,
2017). Collectively, these findings underscore the importance of
examining different ethnicities, X-inactivation models and cleft
subtypes, even though this means addingmoremultiplicity to the
analyses.
We observed a substantial overlap in the associations
identified in the analyses based on the model with X-inactivation
(Figure 2) and those identified in the analyses restricted to girls
only (Figure 3). This was as expected, for the reasons provided in
the Materials and Methods section. Regarding statistical power,
our simulations indicated that there would be sufficient power
for single-SNP analyses based on relative risk ratios (RRR) ≥ 2
(RRR ≥ 2.5 for the smaller sample of CPO triads) (Figure 4). It
could be argued that the assumption of a RRR ≥ 2 or RRR ≥ 2.5
is optimistic in the context of OFCs, or most other complex traits
for that matter. Our current analyses of X-linked PoO effects are
novel and should be regarded as exploratory at this stage. With
continuously accruing sample sizes of OFCs through multiple
international collaborations, we envisage our new methods to
gain wider currency in future analyses of X-linked PoO-effects
in the larger pooled datasets.
This study benefited from being based on the largest collection
of case-parent triads of OFCs to date, which enabled two
major isolated cleft subtypes—CPO and CL/P—to be analyzed
separately and without biases due to population stratification.
In addition, having access to genotype data on two major
ethnicities (Asian and European) enabled a more in-depth
exploration of ethnicity- and sex-specific differences for each
of the identified associations. The new methods presented here
enabled an investigation of the hitherto untested possibility of
PoO effects on the X chromosome, through the use of models
with or without the assumption of X-inactivation in females.
Limitations of the study include a lack of control triads to verify
potential population transmission ratio distortions that could
affect the PoO estimates. This could be the case if a genetic
variant can cause early abortions that are not even registered as
births. However, since the PoO RRR estimates are a ratio of two
transmission distortions (from the mother and from the father),
distortions unrelated to clefting, such as early abortions, would
at least need to exhibit a parent-of-origin dependent pattern
to substantially bias the RRR value. Furthermore, the lack of
a comparable replication cohort precluded a formal validation
of the current findings, which currently makes it difficult to
interpret their relevance to clinical research.
To summarize, we developed new methods for a robust
investigation of PoO-effects on the entire X chromosome and
present the first results of such a screening in the largest
available collection of OFCs triads to date. Our analyses
identified associations with several genes, in particular with
DMD, FGF13, and EFG16 that offer biologically plausible
links to OFCs. The additional identification of associations
with other genes on chromosomal region Xp22.2 deserves
further scrutiny because several genes for clefting syndromes
appear to cluster in this region. Except for DMD, in which
associations were identified in both CPO and CL/P, the rest
of the associations were highly specific for ethnicity, cleft
subtype and X-inactivation model, highlighting the importance
of performing such subanalyses, despite the need to adjust for
additionalmultiple testing.More generally, the newmethodology
presented here is easily adaptable to the study of X-linked
PoO effects in other outcomes that use a family-based study
design.
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